Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
HCV NS5A polymerase inhib
Welcome,
Profile
Billing
Logout
16 Companies
23 Products
23 Products
44 Diseases
57 Trials
7526 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
13
26
39
52
65
78
91
104
117
130
ledipasvir/sofosbuvir
/ Generic mfg.
sofosbuvir/velpatasvir
/ Generic mfg.
Daklinza
(daclatasvir) / BMS
daclatasvir/sofosbuvir
/ Generic mfg.
Technivie
(ombitasvir/paritaprevir/ritonavir) / AbbVie
Viekira Pak
(ombitasvir/paritaprevir/ritonavir/dasabuvir) / AbbVie, Enanta Pharma
odalasvir
(ACH-3102) / J&J, AstraZeneca
Ximency
(daclatasvir/asunaprevir/beclabuvir) / BMS
JNJ-4178
/ J&J
GSK 2336805
/ J&J
velpatasvir
(GS-5816) / Gilead
samatasvir
(IDX719) / Merck (MSD)
ombitasvir
(ABT-267) / AbbVie
JNJ-47910382
/ J&J
Ledipasvir
(GS-5885) / Gilead
coblopasvir
(KW 136) / Beijing Kawin
holybuvir
(SH-229) / Nanjing Sanhome Pharma
AT-777
/ Atea Pharma
BMS 824393
/ BMS
EDP-239
/ Enanta Pharma
AZD 2836
/ AstraZeneca
NATDAC
(daclatasvir) / NATCO, Hetero
PPI-461
/ BioCryst
